Adjuvant Treatment Following Irradical Resection of Stage I-III Non-small Cell Lung Cancer: A Population-based Study

Marnix J.A. Rasing,Max Peters,Mieke J. Aarts,Gerarda J.M. Herder,Anne S.R. van Lindert,Franz M.N.H. Schramel, Femke S. van der Meer,Joost J.C. Verhoeff,Peter S.N. van Rossum

Current Problems in Cancer（2022）

引用 0|浏览8

暂无评分

摘要

Irradical (R1-2) resection for non-small cell lung cancer (NSCLC) is associated with a dismal prognosis. Adjuvant treatment attempts to improve survival outcomes, but evidence on the optimal strategy is limited. The purpose of this study was to compare overall survival (OS) between different adjuvant treatment strategies in these patients.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要